Compare LCII & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCII | LQDA |
|---|---|---|
| Founded | 1956 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.1B |
| IPO Year | N/A | 2018 |
| Metric | LCII | LQDA |
|---|---|---|
| Price | $148.78 | $42.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $109.00 | $38.60 |
| AVG Volume (30 Days) | 360.0K | ★ 2.2M |
| Earning Date | 02-11-2026 | 03-18-2026 |
| Dividend Yield | ★ 3.11% | N/A |
| EPS Growth | ★ 38.80 | N/A |
| EPS | ★ 7.12 | N/A |
| Revenue | ★ $3,992,455,000.00 | $69,216,000.00 |
| Revenue This Year | $10.93 | $1,005.03 |
| Revenue Next Year | $4.29 | $204.13 |
| P/E Ratio | $20.76 | ★ N/A |
| Revenue Growth | 5.74 | ★ 343.41 |
| 52 Week Low | $72.31 | $11.26 |
| 52 Week High | $151.85 | $43.42 |
| Indicator | LCII | LQDA |
|---|---|---|
| Relative Strength Index (RSI) | 78.25 | 69.46 |
| Support Level | $143.56 | $41.09 |
| Resistance Level | $149.73 | $43.42 |
| Average True Range (ATR) | 4.18 | 3.35 |
| MACD | 0.76 | 0.42 |
| Stochastic Oscillator | 89.20 | 91.32 |
LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.